Abstract:Manganese oxide nanocluster‐decorated graphdiyne nanosheets (MnOx/GDY) are developed as multienzyme‐like nanozymes for the treatment of infectious keratitis and loaded into hyaluronic acid‐ and polymethyl methacrylate‐based ocular microneedles (MGMN). MGMN not only exhibits antimicrobial and anti‐inflammatory effects owing to its multienzyme‐like activities, including oxidase, peroxidase, catalase, and superoxide dismutase mimics, but also crosses the ocular barrier and increased bioavailability via the microneedle system, providing a better therapeutic effect than commercial ophthalmic voriconazole, with no obvious microbial resistance or cytotoxicity. Keratitis, an inflammation of the cornea caused by bacterial or fungal infections, is one of the leading causes of severe visual disability and blindness. Keratitis treatment requires both the prevention of infection and the reduction of inflammation. However, owing to their limited therapeutic functions, in addition to the ocular barrier, existing conventional medications are characterized by poor efficacy and low bioavailability, requiring high dosages or frequent topical treatment, which represents a burden on patients and increases the risk of side effects. In this study, manganese oxide nanocluster‐decorated graphdiyne nanosheets (MnOx/GDY) are developed as multienzyme‐like nanozymes for the treatment of infectious keratitis and loaded into hyaluronic acid and polymethyl methacrylate‐based ocular microneedles (MGMN). MGMN not only exhibits antimicrobial and anti‐inflammatory effects owing to its multienzyme‐like activities, including oxidase, peroxidase, catalase, and superoxide dismutase mimics but also crosses the ocular barrier and shows increased bioavailability via the microneedle system. Moreover, MGMN is demonstrated to eliminate pathogens, prevent biofilm formation, reduce inflammation, alleviate ocular hypoxia, and promote the repair of corneal epithelial damage in in vitro, ex vivo, and in vivo experiments, thus providing a better therapeutic effect than commercial ophthalmic voriconazole, with no obvious microbial resistance or cytotoxicity.

Frozen reinforced microneedles loaded with NIR-photothermal nanozyme for keratitis treatment

Photothermal Iron‐Based Riboflavin Microneedles for the Treatment of Bacterial Keratitis via Ion Therapy and Immunomodulation

Iron-doped nanozymes with spontaneous peroxidase-mimic activity as a promising antibacterial therapy for bacterial keratitis

Self-Implantable Core-Shell Microneedle Patch for Long-Acting Treatment of Keratitis via Programmed Drug Release

Multienzyme‐Like Nanozyme Encapsulated Ocular Microneedles for Keratitis Treatment

Exploring the potential of nanoparticles-based polydopamine for effective treatment of refractory keratitis: Mild photothermal loop therapy

Biofilm Microenvironment Activated Supramolecular Nanoparticles for Enhanced Photodynamic Therapy of Bacterial Keratitis

Ε‐poly‐l‐lysine‐modified Polydopamine Nanoparticles for Targeted Photothermal Therapy of Drug‐resistant Bacterial Keratitis

An injectable hydrogel based on sodium alginate and gelatin treats bacterial keratitis through multimodal antibacterial strategy

Antibiotic-free ocular sterilization while suppressing immune response to protect corneal transparency in infectious keratitis treatment

Construction of graphene quantum dot-based dissolving microneedle patches for the treatment of bacterial keratitis

Antibacterial Effect of Nanostructured Cuprous Gold and Silver Oxide Composite Nanoshell on Keratitis

Tannin coordinated nanozyme composite-based hybrid hydrogel eye drops for prophylactic treatment of multidrug-resistant Pseudomonas aeruginosa keratitis

Bacteria‐targeting Nanosilver‐Based Antibacterial Drugs for Efficient Treatment of Drug‐Resistant Bacterial‐Infected Keratitis

Antimicrobial peptides loaded collagen nanosheets with enhanced antibacterial activity, corneal wound healing and M1 macrophage polarization in bacterial keratitis

A Rapid Corneal Healing Microneedle for Efficient Ocular Drug Delivery

DNA Nanoflower Eye Drops with Antibiotic‐Resistant Gene Regulation Ability for MRSA Keratitis Target Treatment

Fabrication of nanozyme-thixotropic anionic hydrogel coating with multi-enzyme-mimicking activity for the treatment of fungal keratitis

Single Administration of a Biodegradable, Separable Microneedle Can Substitute for Repeated Application of Eyedrops in the Treatment of Infectious Keratitis

Development of nanodrug-based eye drops with good penetration properties and ROS responsiveness for controllable release to treat fungal keratitis

Efficient antibacterial AIEgens induced ROS for selective photodynamic treatment of bacterial keratitis